Agarikon (Laricifomes officinalis, also called Fomitopsis officinalis) is a rare tree-dwelling polypore mushroom that researchers have studied for antibacterial, antiviral, anti-inflammatory and immune-related activity. Most of that work comes from laboratory and animal studies, plus a small number of early human trials. We cannot promise health outcomes for it, and neither can the studies. What you can do is read the research accurately and judge any mushroom product by what its label and lab results disclose. That is the approach we take with every mushroom product at Mycelia Link.
TL;DR
- Agarikon is a perennial bracket fungus that grows on old-growth conifers. It has a long history in traditional use and a growing body of lab research.
- Published reviews describe antimicrobial activity in laboratory settings, with compounds such as chlorinated coumarins and lanostane triterpenoids implicated.
- Human data are limited to early trials. Lab results do not automatically carry over to people.
- Agarikon is not the same as Agaricus blazei, a different mushroom that appears in the same searches.
- With any mushroom supplement, look for a clear species, the part of the mushroom used, an extract or powder label, no proprietary blends, and a published Certificate of Analysis (COA).
Table of Contents
- What agarikon is
- What researchers have studied
- How to read the evidence
- Agarikon uses, in plain terms
- Reading a mushroom supplement label
- Safety: who should check first
- Where Mycelia Link fits
- Our perspective
- FAQ
- Sources
What agarikon is
Agarikon is a large, chalky white, hoof-shaped to column-like bracket that grows slowly on old conifers. The inside is soft and crumbly, and it can powder when scraped. Its scientific name has changed over the years, which is why you see both Fomitopsis officinalis and Laricifomes officinalis in papers. They refer to the same fungus.
It is also a rare one. Cornell’s mycology blog notes that it is believed extinct in most of Europe and Asia and can still be found in old-growth forests of the Pacific Northwest, in Washington, Oregon and British Columbia. That rarity matters for shoppers. Wild specimens are scarce, so products usually rely on cultivated mycelium (the thread-like vegetative body of a fungus, grown on a substrate). The label should tell you which part of the mushroom you are getting.

Agarikon is not Agaricus blazei
The names look alike, and search results mix them up. Agaricus blazei (also sold under the name Himematsutake) is a different, edible mushroom in a different genus. Studies on one say nothing about the other, so check the Latin name on any page or label before you rely on the research.
What researchers have studied
The literature on agarikon falls into a few groups. Each describes what was observed in a specific kind of study, not what the mushroom will do for you.
Antibacterial and antiviral activity in the lab
A 2018 peer-reviewed review of Fomitopsis officinalis reports broad-spectrum antimicrobial activity in the literature. The organisms named include Mycobacterium tuberculosis, Yersinia pseudotuberculosis, Staphylococcus aureus and an orthopoxvirus. The review links chlorinated coumarins to the antibacterial and antiviral findings, and lanostane triterpenoids to activity against a parasite called a trypanosome.
A 2019 review covers similar ground. It describes agarikon as containing pharmacologically active compounds and lists antibacterial, antiviral, anti-inflammatory and antitumor activities among those studied. Historical accounts cited there describe use of the mushroom for lung complaints. That is history and lab work, and neither is a claim about what a supplement does today.

Cell and animal research on tumor models
A 2020 study in colorectal cancer models tested multi-species mushroom extract mixtures named AGARIKON.1 and AGARIKON PLUS. In cell lines, the mixtures showed antiproliferative and pro-apoptotic effects. In a mouse model, the authors reported immunostimulatory and antiangiogenic effects, along with increased survival and reduced tumor volume. They also reported no genotoxic effect.
Two points about reading this study. These were mixtures of several mushrooms, so the results cannot be assigned to agarikon alone. And it was a cell and mouse study, which describes what happened in those models, not what happens in people.
Early human trials
Human research is newer and smaller. UC San Diego’s health system described a safety and feasibility study of a 50/50 capsule blend of agarikon and turkey tail, running from December 2020 to December 2022. The same research group has since posted a preprint of a 14-day, double-blind, placebo-controlled trial at two medical centers (UCSD and UCLA) in non-hospitalized adults with COVID-19. A preprint has not yet completed peer review, so treat its findings as preliminary.
Notice that both human studies used agarikon together with turkey tail, in a standardized blend made for the trial. Neither tested a store-bought supplement.
How to read the evidence
Two of the reviews above say plainly where the field stands. The 2018 review points out that extraction and testing methods vary widely and that results are far from standardized, which makes lab findings hard to compare. The 2019 review adds that full clinical trials are costly, and that for complex conditions the human evidence is still largely unestablished.
A practical way to sort what you read:
| Type of evidence | What it can tell you | What it cannot tell you |
|---|---|---|
| Review of the literature | Which activities have been reported and which compounds are implicated | Whether a given product delivers those compounds |
| Cell-culture (in vitro) study | A compound or extract acted on cells in a dish | How the body handles it |
| Animal study | An effect in a model organism under set conditions | The same effect in people |
| Small human trial | Early safety and feasibility signals in a defined group | Results for other people, doses or products |
When a web page says agarikon “supports” or “boosts” something, ask which row of this table the claim comes from. If the page does not say, the claim has nothing behind it you can check.
Agarikon uses, in plain terms
People search for agarikon uses and usually find three things.
- Traditional use. Historical accounts describe the fruiting body being used in folk medicine in the regions where it grew. These accounts are interesting background and are not evidence of benefit.
- Research use. Laboratories study its compounds, its genome and its growth in culture. Cultivating it is difficult, which is part of why research is slow.
- Supplement use. Products are sold as capsules, powders and tinctures, often made from mycelium and often blended with other species. Quality varies a great deal from one label to the next.
The third category is where a reader needs the most help, because the label is all you have.
Reading a mushroom supplement label
The same checks apply to agarikon, turkey tail, reishi or lion’s mane. They are the checks we apply to our own products.
- Species by Latin name. “Agarikon” should be followed by Fomitopsis officinalis or Laricifomes officinalis. Without it, you cannot match the product to any study.
- Fruiting body or mycelium. Studies describe both, and they are not interchangeable. The label should say which one is in the bottle.
- Extract or powder. The two differ in what is concentrated. Our guide to mushroom extract versus powder explains how to buy by beta-glucan content, extraction method and COA.
- No proprietary blends. A blend that lists a combined weight hides how much of each mushroom you get. The trials above used a defined 50/50 ratio, which is the kind of disclosure to expect.
- A published COA from an independent lab. A Certificate of Analysis is the lab’s report on what a specific batch contains and whether it passed tests for contaminants. It should be easy to find, not available on request only.
If you are comparing categories, our functional mushroom supplements guide and the functional mushroom health benefits list walk through what is studied for the species we work with. Our write-up on turkey tail is a good companion, since turkey tail is the species paired with agarikon in the human trials above.
Safety: who should check first
There is no agarikon-specific safety guidance for the general public. The studies above were run under medical supervision with defined products, so their safety findings do not extend to every supplement on the market.
Some simple precautions apply to any mushroom supplement:
- Follow the directions on the product label. Do not build your own dosing plan from a study.
- Talk to a doctor or pharmacist before starting if you take prescription medication, are pregnant or nursing, have an autoimmune condition, or are preparing for surgery. Our guide to avoiding mushroom supplement interactions lists what to bring to that conversation.
- Do not forage agarikon yourself. It is rare and protected by its scarcity, and misidentifying wild mushrooms can be dangerous. Buy products with a species name and a COA instead.
- Stop and contact a healthcare professional if you have any unexpected reaction.
Where Mycelia Link fits
We do not make health promises about mushrooms. Our functional mushroom supplements are third-party tested, the Certificates of Analysis are published, labels are clear, and there are no proprietary blends. If you want to compare formats, our mushroom supplements page is the place to start, and if you use skincare, our handmade mushroom-infused soaps follow the same testing approach.
M-Link Pro members get member pricing. M-Link Pro costs $29.99 per month or $299 per year. Every purchase is covered by our Customer Satisfaction Guarantee: if you are not satisfied, contact us at info@mycelialink.com or text or call (580) 823-0004 and we will make it right.

Merch proceeds go to One Tree Planted, a reforestation charity, which seems fitting for a mushroom that depends on old forests. You can see the range on our shop page.
Our perspective
Agarikon is a good example of why we insist on showing our work. The research is genuinely interesting: reviews describe antimicrobial activity in the lab, and early human trials are underway. But the studies use specific preparations, and the shelf is full of products that say “agarikon” without saying which part, which species or how much.
That gap is where hidden ingredients live. A proprietary blend can put a famous name on the front and a small amount of it inside. We think the better answer is plain labels, no proprietary blends, third-party testing and published COAs, so you can see what is in each batch before you decide.
We also think explaining what a lab result shows is more useful than promising an outcome. A COA will not tell you that a mushroom will do something for you. It will tell you what is in the product and what is not. That is the standard we hold our mushroom supplements and soaps to, and it is why we describe studies as studied, not proven.
Mycelia Link Industries
FAQ
What are the benefits of agarikon?
Researchers have studied agarikon for antibacterial, antiviral, anti-inflammatory and immune-related activity, mostly in laboratory and animal work. Early human trials exist, but they used specific blends and are small. No study establishes that a supplement will produce a particular benefit for you.
Is agarikon the same as Agaricus blazei?
No. Agarikon is Fomitopsis officinalis (or Laricifomes officinalis), a woody bracket fungus from old conifers. Agaricus blazei is a separate, edible mushroom from a different genus. Research on one does not apply to the other.
Where does agarikon grow?
It is believed to be extinct across most of Europe and Asia. Cornell’s mycology blog reports that it survives in old-growth forests of the Pacific Northwest, in Washington, Oregon and British Columbia. Because wild specimens are scarce, products generally use cultivated mycelium.
Is agarikon safe to take?
There is no agarikon-specific safety guidance for the general public. Follow the label on any product, and check with a doctor or pharmacist first if you take medication, are pregnant or nursing, or have a medical condition.
How do I choose a mushroom supplement with confidence?
Look for the Latin species name, the part of the mushroom used, an extract or powder statement, no proprietary blends and a published third-party COA. Those five details let you match a product to the studies and see what a batch contains.
Sources
- Antimicrobial properties of Fomitopsis officinalis (2018 review)
- Fomitopsis officinalis mushroom: ancient gold mine of pharmacologically active compounds (2019 review)
- Antitumor, immunomodulatory and antiangiogenic efficacy of medicinal mushroom extract mixtures (2020)
- UC San Diego Health: Can ancient botanical therapies help treat COVID-19?
- Polypore mushroom mycelia for active COVID-19 infection: randomized clinical trial (preprint)
- Agarikon: Cornell Mushroom Blog
Recommended
- Antrodia Benefits: What the Research Shows and What It Doesn’t
- Shiitake Benefits: Small Trials, Cooking, and COA Checks
- Reishi Benefits: What Human Trials and Third Party Tests Actually Show
- Chaga Benefits, Lab vs Human Evidence, and a COA Vetting Checklist
This article is for informational and educational purposes only and is not medical advice. Research peptides sold by Mycelia Link are for laboratory research use only and are not for human or animal consumption. Statements about dietary supplements have not been evaluated by the Food and Drug Administration; these products are not intended to diagnose, treat, cure or prevent any disease.
